Acute effects of the ACE inhibitor enalaprilat
on the pulmonary, cerebral and systemic blood flow and resistance after the bidirectional cavopulmonary connection.
Differential effects of quinaprilat and enalaprilat
on endothelial function of conduit arteries in patients with chronic heart failure.
Commercial distribution of both enalaprilat injection and enalapril maleate tablets will commence immediately.
The launch of enalaprilat injection is a good example of the strength of our internal development and regulatory ability with Faulding receiving tentative approval from the FDA in less than 12 months when the average approval time is 20 months.
International pharmaceutical and health care company, F H Faulding & Co Limited (Faulding), today announced that its Faulding Pharmaceuticals division has received final approval from the Food and Drug Administration (FDA) in the United States for its abbreviated new drug application (ANDA) for enalaprilat
injection, following the expiry of the paediatric exclusivity period on 22 August 2000.
has received a tentative approval of an Abbreviated New Drug Application (ANDA) from the Food and Drug Administration (FDA) for Enalaprilat Injection, a drug that is indicated for the treatment of hypertension.
sales of Enalaprilat were approximately $40 million in 1999.
The three other approvals include the final approval for labetalol HCI and cytarabine 2g/20mL during November 1999 and December 1999 respectively, and the tentative approval for enalaprilat
injection in February 2000.
VASOTEC (Enalapril Maleate) is the maleate salt of enalapril, the ethyl ester of a long-acting angiotensin converting enzyme inhibitor, enalaprilat